Susquehanna Fundamental Investments LLC Acquires New Shares in Option Care Health, Inc. (NASDAQ:OPCH)

Susquehanna Fundamental Investments LLC bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 285,819 shares of the company's stock, valued at approximately $6,631,000. Susquehanna Fundamental Investments LLC owned about 0.17% of Option Care Health as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in OPCH. Vanguard Group Inc. increased its position in shares of Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock worth $448,118,000 after purchasing an additional 75,313 shares during the last quarter. Wellington Management Group LLP boosted its stake in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock worth $425,143,000 after buying an additional 8,400,208 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of Option Care Health by 17.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock valued at $92,518,000 after acquiring an additional 591,042 shares during the period. Norges Bank acquired a new position in shares of Option Care Health in the 4th quarter worth approximately $60,219,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Option Care Health by 6.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after acquiring an additional 147,054 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Insider Buying and Selling

In other news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.64% of the stock is owned by insiders.

Option Care Health Stock Performance

Shares of OPCH opened at $32.90 on Monday. Option Care Health, Inc. has a 1 year low of $21.39 and a 1 year high of $35.53. The stock has a market capitalization of $5.40 billion, a PE ratio of 27.65, a PEG ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The stock has a 50-day simple moving average of $33.36 and a 200-day simple moving average of $28.76.

Analysts Set New Price Targets

A number of brokerages have issued reports on OPCH. JMP Securities reissued a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and lifted their target price for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JPMorgan Chase & Co. boosted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. Finally, Barrington Research reissued an "outperform" rating and issued a $38.00 price objective on shares of Option Care Health in a research note on Monday, April 21st. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $33.75.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.